home / stock / adag / adag quote
Last: | $2.735 |
---|---|
Change Percent: | 0.0% |
Open: | $2.62 |
Close: | $2.735 |
High: | $2.8 |
Low: | $2.61 |
Volume: | 5,417 |
Last Trade Date Time: | 07/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.735 | $2.62 | $2.735 | $2.8 | $2.61 | 5,417 | 07-24-2024 |
$2.62 | $2.6 | $2.62 | $2.64 | $2.5 | 16,666 | 07-23-2024 |
$2.6302 | $2.5448 | $2.6302 | $2.72 | $2.5 | 10,092 | 07-22-2024 |
$2.5101 | $2.55 | $2.5101 | $2.61 | $2.5 | 7,363 | 07-19-2024 |
$2.57 | $2.55 | $2.57 | $2.78 | $2.55 | 14,719 | 07-18-2024 |
$2.61 | $2.63 | $2.61 | $2.64 | $2.57 | 4,966 | 07-17-2024 |
$2.6 | $2.72 | $2.6 | $2.79 | $2.6 | 24,873 | 07-16-2024 |
$2.73 | $2.65 | $2.73 | $2.91 | $2.65 | 10,856 | 07-15-2024 |
$2.76 | $2.8401 | $2.76 | $2.8655 | $2.7 | 4,420 | 07-12-2024 |
$2.71 | $2.7501 | $2.71 | $2.84 | $2.71 | 6,896 | 07-11-2024 |
$2.76 | $2.8418 | $2.76 | $2.9 | $2.76 | 14,948 | 07-10-2024 |
$2.75 | $2.81 | $2.75 | $2.81 | $2.66 | 20,743 | 07-09-2024 |
$2.8199 | $2.89 | $2.8199 | $2.9 | $2.67 | 7,381 | 07-08-2024 |
$2.83 | $2.8 | $2.83 | $2.8674 | $2.75 | 14,421 | 07-05-2024 |
$2.9 | $2.99 | $2.9 | $3.05 | $2.88 | 5,291 | 07-04-2024 |
$2.9 | $2.99 | $2.9 | $3.05 | $2.88 | 5,291 | 07-03-2024 |
$2.99 | $2.99 | $2.99 | $2.99 | $2.99 | 1,116 | 07-02-2024 |
$3.05 | $2.95 | $3.05 | $3.1 | $2.95 | 12,631 | 07-01-2024 |
$3.061 | $2.97 | $3.061 | $3.095 | $2.97 | 3,069 | 06-28-2024 |
$3.085 | $2.91 | $3.085 | $3.18 | $2.86 | 38,705 | 06-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO and SUZHOU, China, July 12, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced a poster presentation at the upcoming ESMO Congress, taking place in Barcel...
SAN DIEGO and SUZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 20...
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...